VRE Endocarditis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Daptomycin 8–10 mg/kg IV daily
VanA-type VRE E. faecium endocarditis resistant to both Ampicillin and Vancomycin is extremely challenging. Daptomycin at high dose (8–10 mg/kg daily) is the most evidence-supported option for VRE endocarditis. Ampicillin and Vancomycin are ineffective. Linezolid is bacteriostatic and has inferior outcomes for endocarditis (though it may be used in combination). Teicoplanin is ineffective against VanA phenotype. Surgical valve replacement should be considered early given the limited antibiotic options and poor prognosis.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/infections